Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (8): 667-670.DOI: 10.3969/j.issn.1673-8640.2016.08.007

• Orginal Article • Previous Articles     Next Articles

The applicability of glycated hemoglobin A1c for patients with hemoglobin H disease

XU Anping, JI Ling, CHEN Weidong, XIA Yong, YU Jing, ZHOU Yu, LI Lu   

  1. Department of Clinical Laboratory,Shenzhen Hospital,Peking University,Shenzhen 518036,Guangdong,China
  • Received:2015-07-23 Online:2016-08-31 Published:2016-09-01

Abstract:

Objective To investigate the influence of hemoglobin H (HbH) disease on 4 kinds of glycated hemoglobin A1c(HbA1c) systems and the applicability of HbA1c for patients with HbH disease. Methods A total of 27 samples with HbH disease and 30 control samples were collected. HbA1c determinations were performed by boronate affinity high performance liquid chromatography,capillary electrophoresis,turbidimetric immunoassay and ion exchange high performance liquid chromatography. The difference of the 4 systems was compared. Fasting glucose(FG) and glycated serum protein(GSP) were determined as well. The differences of FG,GSP,HbA1c and average glucose were compared between control and HbH disease groups. Results Compared with boronate affinity high performance liquid chromatography(Ultra2),P values were 0.08,0.89 and 0.64,with no statistical significance(P>0.05). The differences of FG and GSP had no statistical significance between control and HbH disease groups(P>0.05). The differences of HbA1c and average glucose had statistical significance between control and HbH disease groups(P<0.01). Conclusions HbA1c of HbH disease group can not reflect the real level of average glucose,and it is not applicable for long-term blood glucose monitoring in patients with HbH disease.

Key words: Glycated hemoglobin A1c, Hemoglobin H, Red blood cell life span, Average glucose

CLC Number: